UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Lower Neurocognitive Functioning in HIV-Exposed Uninfected Children Compared With That in HIV-Unexposed Children

Journal of acquired immune deficiency syndromes (1999), 2022-04, Vol.89 (4), p.441-447

2022

Volltextzugriff (PDF)

Ibalizumab‐uiyk as a bridge therapy for a patient with drug‐resistant HIV‐1 infection receiving chemotherapy: A case report

Journal of clinical pharmacy and therapeutics, 2021-08, Vol.46 (4), p.1185-1187

2021

Volltextzugriff (PDF)

Concentrations of Efavirenz, Tenofovir, and Emtricitabine in Obesity: A Cross-Sectional Study

Journal of acquired immune deficiency syndromes (1999), 2022-09, Vol.91 (1), p.101-108

2022

Volltextzugriff (PDF)

Association Between the Awareness of Antiretroviral Drugs-Related Services and Drug Accessibility During the COVID-19 Pandemic Among Patients Undergoing Antiretroviral Therapy: A Cross-Sectional Study

AIDS and behavior, 2023-03, Vol.27 (3), p.891-900

2023

Volltextzugriff (PDF)

Individualized antiretroviral therapeutic approaches: less can be more

AIDS (London), 2017-05, Vol.31 (8), p.1065-1071

2017

Volltextzugriff (PDF)

Long‐acting injectable cabotegravir for PrEP: A game‐changer in HIV prevention?

HIV medicine, 2023-06, Vol.24 (6), p.653-663

2023

Volltextzugriff (PDF)

HBV, HCV, and HBV/HCV co‐infection among HIV‐positive patients in Hunan province, China: Regimen selection, hepatotoxicity, and antiretroviral therapy outcome

Journal of medical virology, 2018-03, Vol.90 (3), p.518-525

2018

Volltextzugriff (PDF)

Improved Prediction of Salvage Antiretroviral Therapy Outcomes Using Ultrasensitive HIV-1 Drug Resistance Testing

Clinical infectious diseases, 2014-08, Vol.59 (4), p.578-588

2014

Volltextzugriff (PDF)

Abnormal laboratory findings and plasma concentration monitoring of lopinavir and ritonavir in COVID‐19

British journal of clinical pharmacology, 2021-03, Vol.87 (3), p.1547-1553

2021

Volltextzugriff (PDF)

Epidemiology of human immunodeficiency virus (HIV) drug resistance in HIV patients with virologic failure of first‐line therapy in the country of Georgia

Journal of medical virology, 2019-02, Vol.91 (2), p.235-240

2019

Volltextzugriff (PDF)

New Perspectives on the Virologic Consequences of M184V or I in Human Immunodeficiency Virus-1 Reverse Transcriptase

The Journal of infectious diseases, 2020-09, Vol.222 (7), p.1067-1069

Kuritzkes, Daniel R

2020

Volltextzugriff (PDF)

P-4 Low level viremia at the beginning and in course of long-acting treatment with injectable cabotegravir and rilpivirine

Sexually transmitted infections, 2024-06, Vol.100 (Suppl 1), p.A153-A153

2024

Volltextzugriff (PDF)

P-25 Switching to long-acting cabotegravir/rilpivirine: data from an Italian monocentric cohort

Sexually transmitted infections, 2024-06, Vol.100 (Suppl 1), p.A170-A171

2024

Volltextzugriff (PDF)

People living with HIV travel farther to access healthcare: a population‐based geographic analysis from rural Uganda

Journal of the International AIDS Society, 2016-01, Vol.19 (1), p.20171-n/a

2016

Volltextzugriff (PDF)

Dolutegravir Inhibition of Matrix Metalloproteinases Affects Mouse Neurodevelopment

Molecular neurobiology, 2021-11, Vol.58 (11), p.5703-5721

2021

Volltextzugriff (PDF)

P189 Evaluation of aptima HIV-1 quant assay performance using plasma and dried blood spots

Sexually transmitted infections, 2019-07, Vol.95 (Suppl 1), p.A135

2019

Volltextzugriff (PDF)

P418 Uptake of HIV pre-exposure prophylaxis (PrEP) in western nigeria: are healthcare providers prepared for the key populations?

Sexually transmitted infections, 2019-07, Vol.95 (Suppl 1), p.A200

2019

Volltextzugriff (PDF)

P454 Emergency Department (ED)-based HIV Pre-Exposure Prophylaxis (PrEP) referral program – using EDs as a portal for PrEP services

Sexually transmitted infections, 2019-07, Vol.95 (Suppl 1), p.A213

2019

Volltextzugriff (PDF)

P429 Does HIV pre-exposure prophylaxis (PrEP) initiation in sexual health clinics impact subsequent HIV risk?

Sexually transmitted infections, 2019-07, Vol.95 (Suppl 1), p.A204

2019

Volltextzugriff (PDF)

P442 Implementing pre-exposure prophylaxis for HIV: experiences in a health department based STI clinic

Sexually transmitted infections, 2019-07, Vol.95 (Suppl 1), p.A208

2019

Volltextzugriff (PDF)

P162 Unsuppressed viral load (VL) by HIV exposure category among people living with HIV in british columbia(BC), canada: 2005–2015

Sexually transmitted infections, 2019-07, Vol.95 (Suppl 1), p.A128

2019

Volltextzugriff (PDF)

P430 Predictors of interest in switching from daily to on-demand HIV Pre-Exposure Prophylaxis (PrEP) among australians

Sexually transmitted infections, 2019-07, Vol.95 (Suppl 1), p.A204

2019

Volltextzugriff (PDF)

Estimating the lost benefits of antiretroviral drug use in South Africa

Journal of acquired immune deficiency syndromes (1999), 2008-12, Vol.49 (4), p.410-415

2008

Volltextzugriff (PDF)

Lipid-Based Nutrient Supplements Are Feasible As a Breastmilk Replacement for HIV-Exposed Infants from 24 to 48 Weeks of Age

The Journal of nutrition, 2013-05, Vol.143 (5), p.701-707

2013

Volltextzugriff (PDF)

Idiopathic intracranial hypertension associated with anaemia, secondary to antiretroviral drug in a human immunodeficiency virus positive patient

Indian journal of ophthalmology, 2018-01, Vol.66 (1), p.168-169

2018

Volltextzugriff (PDF)

1 – 25 von 20.539

Suche als RSS-Feed

Aktive Filter

KollektionApplied Social Sciences Index & Abstracts (ASSIA)

ThemaAntiretroviral Therapy, Highly Active

KollektionLWW Total

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(19.613)
Mit Volltextzugriff
(14.884)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(17.224)
Life Sciences & Biomedicine
(17.099)
Humans
(16.073)
Hiv
(14.428)
Human Immunodeficiency Virus
(13.322)
Infectious Diseases
(12.194)
Hiv Infections - Drug Therapy
(11.471)
Antiretroviral Drugs
(11.050)
Female
(9.943)
Male
(9.490)
Adult
(8.473)
Immunology
(8.057)
Antiretroviral Therapy
(6.097)
Aids
(5.543)
Middle Aged
(5.511)
Drug Therapy
(5.278)
Biological And Medical Sciences
(5.224)
Medical Sciences
(5.168)
Anti-Hiv Agents - Therapeutic Use
(5.037)
Antiretroviral Agents
(4.776)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Journals@Ovid Complete
(20.539)
MEDLINE
(16.338)
EZB Electronic Journals Library
(10.532)
IngentaConnect Journals
(7.955)
Publisher or Other Site
(6.967)
IngentaConnect Journals
(6.561)
Wiley Online Library - AutoHoldings Journals
(4.138)
Springer Nature - Complete Springer Journals
(3.415)
Oxford University Press Journals Current
(3.102)
Oxford Journals 2020 Medicine
(3.010)
JSTOR
(2.623)
Wiley Online Library Full Collection 2018
(2.466)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(1.721)
Elsevier ScienceDirect Journals Complete
(1.092)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(1.044)
Sociological Abstracts
(1.011)
BMJ Journals
(1.009)
EBSCOhost Psychology and Behavioral Sciences Collection
(952)
EBSCOhost Business Source Ultimate
(775)
Taylor & Francis Journals
(697)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Acquired Immune Deficiency Syndromes
(2.316)
Aids
(1.756)
Jaids-Journal Of Acquired Immune Deficiency Syndromes
(1.689)
Journal Of The International Aids Society
(1.358)
Clinical Infectious Diseases
(1.285)
Clinical Infectious Diseases/clinical Infectious Diseases
(980)
Aids And Behavior
(940)
The Journal Of Infectious Diseases
(842)
Hiv Medicine
(695)
The Lancet
(685)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(31)

Menü

Weitere Dienste

Einstellungen

Lower Neurocognitive Functioning in HIV-Exposed Uninfected Children Compared With That in HIV-Unexposed Children

Ibalizumab‐uiyk as a bridge therapy for a patient with drug‐resistant HIV‐1 infection receiving chemotherapy: A case report

Concentrations of Efavirenz, Tenofovir, and Emtricitabine in Obesity: A Cross-Sectional Study

Association Between the Awareness of Antiretroviral Drugs-Related Services and Drug Accessibility During the COVID-19 Pandemic Among Patients Undergoing Antiretroviral Therapy: A Cross-Sectional Study

Individualized antiretroviral therapeutic approaches: less can be more

Long‐acting injectable cabotegravir for PrEP: A game‐changer in HIV prevention?

HBV, HCV, and HBV/HCV co‐infection among HIV‐positive patients in Hunan province, China: Regimen selection, hepatotoxicity, and antiretroviral therapy outcome

Improved Prediction of Salvage Antiretroviral Therapy Outcomes Using Ultrasensitive HIV-1 Drug Resistance Testing

Abnormal laboratory findings and plasma concentration monitoring of lopinavir and ritonavir in COVID‐19

Epidemiology of human immunodeficiency virus (HIV) drug resistance in HIV patients with virologic failure of first‐line therapy in the country of Georgia

New Perspectives on the Virologic Consequences of M184V or I in Human Immunodeficiency Virus-1 Reverse Transcriptase

P-4 Low level viremia at the beginning and in course of long-acting treatment with injectable cabotegravir and rilpivirine

P-25 Switching to long-acting cabotegravir/rilpivirine: data from an Italian monocentric cohort

People living with HIV travel farther to access healthcare: a population‐based geographic analysis from rural Uganda

Dolutegravir Inhibition of Matrix Metalloproteinases Affects Mouse Neurodevelopment

P189 Evaluation of aptima HIV-1 quant assay performance using plasma and dried blood spots

P418 Uptake of HIV pre-exposure prophylaxis (PrEP) in western nigeria: are healthcare providers prepared for the key populations?

P454 Emergency Department (ED)-based HIV Pre-Exposure Prophylaxis (PrEP) referral program – using EDs as a portal for PrEP services

P429 Does HIV pre-exposure prophylaxis (PrEP) initiation in sexual health clinics impact subsequent HIV risk?

P442 Implementing pre-exposure prophylaxis for HIV: experiences in a health department based STI clinic

P162 Unsuppressed viral load (VL) by HIV exposure category among people living with HIV in british columbia(BC), canada: 2005–2015

P430 Predictors of interest in switching from daily to on-demand HIV Pre-Exposure Prophylaxis (PrEP) among australians

Estimating the lost benefits of antiretroviral drug use in South Africa

Lipid-Based Nutrient Supplements Are Feasible As a Breastmilk Replacement for HIV-Exposed Infants from 24 to 48 Weeks of Age

Idiopathic intracranial hypertension associated with anaemia, secondary to antiretroviral drug in a human immunodeficiency virus positive patient

Aktive Filter

Suchergebnisse filtern